•
TV
TVGN
Tevogen Bio Holdings Inc. Common Stock
polygonBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
--
Price Chart
Market Cap
63.22M
Volume
152.66K
52W High
$1.92
52W Low
$0.30
Open
$0.32
Prev Close
$0.32
Day Range
0.32 - 0.33
About Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
Latest News
Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook
GlobeNewswire Inc.•Dec 8
Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn
GlobeNewswire Inc.•Nov 3
Tevogen Updates on TVGN 489 Following Growing Long COVID Patient Interest
GlobeNewswire Inc.•Oct 15
Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489’s Potential Impact for 20 Million Americans
GlobeNewswire Inc.•Sep 19
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
GlobeNewswire Inc.•Aug 18
Healthcare AI Market Explodes 38.5% Annually as Diagnostics Gain FDA Traction
Benzinga•Aug 12
Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
GlobeNewswire Inc.•Aug 11
Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions
GlobeNewswire Inc.•Aug 6